Statement on the use of wearable cardioverter defibrillators;Stellungnahme zum Einsatz des tragbaren Kardioverter/Defibrillators

Kardiologe

Volumn 9, Issue 2, 2015, Pages 165-170

  Schwab, J O ^a   Bansch D ^b   Israel, C ^c   Nowak, B ^d  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c EVANGELISCHES KRANKENHAUS   (Germany)

^d CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

Author keywords

Indications; Mortality; Sudden cardiac death; Tachyarrhythmia; Ventricular fibrillation

Indexed keywords

ARTICLE; CARDIAC PATIENT; DEFIBRILLATOR; DEVICE INFECTION; HEART TRANSPLANTATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PACEMAKER IMPLANTATION; SUDDEN CARDIAC DEATH; WEARABLE CARDIOVERTER DEFIBRILLATOR;

EID: 84925485293     PISSN: 18649718     EISSN: 18649726     Source Type: Journal    
DOI: 10.1007/s12181-015-0651-y     Document Type: Article

References (29)

1. o A (2006) ACC/AHA/ESC 2006 guidlines for managment of patients with ventricular arrhythmias and the prevention of sudden cardiac deat. Europace 8:746–837
2. http://www.hrsonline.org/content/download/8564/375099/file/SCD%20Primary%20Prevention%20Protocols.pdf
3. Klein HU, Goldenberg I, Moss AJ (2013) Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Eur Heart J 34(29):2230–2242
4. Klein HH, Kärmer A, Pieske BM et al (2010) Fahreignung bei kardiovaskulären Erkrankungen. Kardiologe 4(6):441–473
5. Chung MK, Szymkiewicz SJ, Shao M et al (2010) Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 56(3):194–203
6. Klein HU, Meltendorf U, Reek S et al (2010) Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol 33(3):353–367
7. Lang CC, Hankins S, Hauff H et al (2003) Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home. J Heart Lung Transplant 22(4):419–426
8. Sandner SE, Wieselthaler G, Zuckermann A et al (2001) Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 104(12 Suppl 1):I171–I176
9. Da Rosa MR, Sapp JL, Howlett JG et al (2007) Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation. J Heart Lung Transplant 26(12):1336–1339
10. Lampert R, Hayes DL, Annas GJ et al (2010) HRS expert consensus statement on the management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 7(7):1008–1026
11. Peters S, Klein HU (2011) WCD LifeVest: risk stratification in a case of tako-tsubo cardiomyopathy with QT interval prolongation. Herz 37(2):219–221
12. Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathie. N Engl J Med 350(21):2151–2158
13. Kadish A, Schaechter A, Subacius H et al (2006) Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol 47:2477–2482
14. Hilfiker-Kleiner D, Meyer GP, Schieffer E et al (2007) Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 50(24):2354–2355
15. Sliwa K, Blauwet L, Tibazarwa K et al (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121(13):1465–1473
16. Saltzberg MT, Szymkiewicz S, Bianco NR (2012) Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 18(1):21–27
17. Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27(11):1341–1381
18. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10(10):933–989
19. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883
20. Bigger JT Jr (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337(22):1569–1575
21. Feldman AM, Klein H, Tchou P et al (2004) Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 27(1):4–9
22. Zishiri E, Williams S, Cronin EM et al (2013) Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol 6(1):117–128
23. Pouleur AC, Barkoudah E, Uno H et al (2010) Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 122(6):597–602
24. Dorian P, Hohnloser SH, Thorpe KE et al (2010) Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT). Circulation 122(25):2645–2652
25. Hohnloser SH, Kuck KH, Dorian P et al (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351(24):2481–2488
26. Steinbeck G, Andresen D, Seidl K et al (2009) Defibrillator implantation early after myocardial infarction. N Engl J Med 361(15):1427–1436
27. Gronda E, Bourge RC, Costanzo MR et al (2006) Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates – 2006. J Heart Lung Transplant 25(9):1043–1056
28. Epstein AE, Dimarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 5(6):e1–e62
29. Dickstein K, Vardas PE, Auricchio A et al (2010) 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 31(21):2677–2687